Suppr超能文献

人乳中的一种生长激素/催乳素结合蛋白。

A growth hormone/prolactin-binding protein in human milk.

作者信息

Mercado M, Baumann G

机构信息

Department of Medicine, Northwestern University Medical School, Chicago, Illinois 60611.

出版信息

J Clin Endocrinol Metab. 1994 Dec;79(6):1637-41. doi: 10.1210/jcem.79.6.7989468.

Abstract

In the course of studies of the distribution of GH-binding proteins (GHBP) in biological fluids, we identified a human (h) GH/hPRL-binding component in human milk. To characterize its nature, 16 human milk samples were analyzed by molecular exclusion chromatography after incubation with monomeric [125I]hGH. All samples showed a peak indicative of a hGH-containing complex with a mol wt of 52 kilodaltons (kDa)--considerably smaller than the high affinity GH-binding protein complex in plasma (80-85 kDa). Binding of [125I]hGH was inhibited in a dose-dependent fashion by unlabeled hGH and to a lesser extent by hPRL, but not by oGH. Scatchard analysis yielded a Ka of 2.1 x 10(8) M-1 and a maximum binding capacity of 5.1 micrograms/L for hGH, and a Ka of 0.5 x 10(8) M-1 for hPRL. The derived molecular size of the milk GH/PRL-binding protein (BP) is 30 kDa, assuming 1:1 binding stoichiometry. The milk BP was not immunoprecipitable with any of 4 monoclonal antibodies directed against the hGH receptor or with a polyclonal antiserum directed against the hPRL receptor. The milk BP bound to hGH affinity columns, but unlike the GHBP in human plasma, did not bind to wheat germ lectin columns, suggesting different or no glycosylation. We conclude that human milk contains a high affinity GH/PRLBP that differs from the serum GHBP in its ligand specificity (binding both hGH and hPRL), molecular size, immunological, and glycosylation characteristics. Based on its immunochemical and ligand-binding characteristics, it does not appear to be a truncated GH receptor such as the plasma GHBP. Its lack of immunoreactivity with the one available antiserum also does not support its identity with a truncated PRL receptor. However, it cannot be excluded that the milk BP may represent a proteolytically or otherwise altered truncated form of the PRL receptor (or, less likely, the GH receptor) that maintains some binding activity, but has its immunological epitope(s) disabled. The precise nature and function of this protein remain to be defined.

摘要

在研究生长激素结合蛋白(GHBP)在生物体液中的分布过程中,我们在人乳中鉴定出一种人(h)生长激素/人催乳素结合成分。为了确定其性质,将16份人乳样品与单体[125I]hGH孵育后,通过分子排阻色谱法进行分析。所有样品均显示出一个峰值,表明存在一种分子量为52千道尔顿(kDa)的含hGH复合物——远小于血浆中的高亲和力生长激素结合蛋白复合物(80 - 85 kDa)。未标记的hGH以剂量依赖性方式抑制[125I]hGH的结合,hPRL的抑制作用较小,而oGH则无抑制作用。Scatchard分析得出hGH的解离常数(Ka)为2.1×10⁸ M⁻¹,最大结合容量为5.1微克/升,hPRL的Ka为0.5×10⁸ M⁻¹。假设结合化学计量比为1:1,人乳生长激素/催乳素结合蛋白(BP)的推导分子大小为30 kDa。该人乳BP不能被4种针对hGH受体的单克隆抗体中的任何一种或针对hPRL受体的多克隆抗血清免疫沉淀。人乳BP能与hGH亲和柱结合,但与人类血浆中的GHBP不同,它不与麦胚凝集素柱结合,这表明其糖基化情况不同或无糖基化。我们得出结论,人乳中含有一种高亲和力的生长激素/催乳素结合蛋白(GH/PRLBP),其在配体特异性(结合hGH和hPRL)、分子大小、免疫学和糖基化特征方面与血清GHBP不同。基于其免疫化学和配体结合特征,它似乎不是一种截短的生长激素受体,如血浆GHBP。它与现有的一种抗血清缺乏免疫反应性也不支持其与截短的催乳素受体相同。然而,不能排除人乳BP可能代表一种经蛋白水解或其他方式改变的截短形式的催乳素受体(或者可能性较小的生长激素受体),该受体保留了一些结合活性,但免疫表位被破坏。这种蛋白质的确切性质和功能仍有待确定。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验